Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AGE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | AGE |
| Key Genes/Proteins | AGER |
| Related Diseases | AD, ALS, neurodegenerative diseases, PD |
| Linked Hypotheses | 3 hypotheses |
Knowledge base pages for this entity
graph TD
AGE["AGE"]
AGE -->|"risk_factor_for"| Alzheimer_s_Disease["Alzheimer's Disease"]
AGE -->|"risk_factor_for"| Parkinson_s_Disease["Parkinson's Disease"]
AGE -->|"risk_factor_for"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
AGE -->|"downregulates"| Microglial_Phagocytosis_of_Amy["Microglial Phagocytosis of Amyloid-beta"]
AGE -->|"upregulates"| Microglial_Phagocytosis_of_Syn["Microglial Phagocytosis of Synapses"]
AGE -->|"risk_factor_for"| Glaucoma["Glaucoma"]
AGE -->|"modulates"| Mature_Neuronal_Fate["Mature Neuronal Fate"]
AGE -->|"risk_factor_for"| Dementia["Dementia"]
PARKINSON["PARKINSON"] -->|"increases_risk"| AGE
autophagy["autophagy"] -->|"regulates"| AGE| Target | Relation | Type | Str |
|---|---|---|---|
| Dopaminergic Neurodegeneration | associated_with | process | 0.95 |
| Neuronal Fate Instability | associated_with | phenotype | 0.95 |
| Alzheimer's Disease | risk_factor_for | disease | 0.95 |
| Parkinson's Disease | risk_factor_for | disease | 0.90 |
| Amyotrophic Lateral Sclerosis | risk_factor_for | disease | 0.90 |
| Microglial Phagocytosis of Amyloid-β | downregulates | process | 0.90 |
| Microglial Phagocytosis of Synapses | upregulates | process | 0.90 |
| Strem2 | upregulates | protein | 0.88 |
| Mature Neuronal Fate | modulates | phenotype | 0.85 |
| Trem2 Processing | modulates | process | 0.85 |
| Glaucoma | risk_factor_for | disease | 0.85 |
| microglia-peripheral macrophage differentiation | regulates | process | 0.85 |
| Dementia | risk_factor_for | disease | 0.82 |
| Dementia Development | associated_with | phenotype | 0.80 |
| neurodegenerative diseases | risk_factor | disease | 0.80 |
| Microglial Population Differences | associated_with | phenotype | 0.80 |
| Hyperphosphorylated Tau Accumulation | associated_with | process | 0.80 |
| microglial heterogeneity | drives | phenotype | 0.80 |
| Trem2 Function | modulates | mechanism | 0.78 |
| terminally inflammatory microglia | activates | cell_type | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| ALS | associated_with | disease | 0.64 |
| AD | associated_with | disease | 0.64 |
| PD | associated_with | disease | 0.64 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Microglia Phenotype | associated_with | phenotype | 0.85 |
| Asc Clusters Density | correlates_with | biomarker | 0.80 |
| PARKINSON | increases_risk | disease | 0.80 |
| autophagy | regulates | pathway | 0.70 |
| AGER | co_associated_with | gene | 0.30 |
| Bd-Tau | correlates_with | biomarker | 0.30 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Epigenetic clocks association with brain aging patterns in older women | exploratory | cognitive impairment and demen | 0.900 | 0.00 | human patients | proposed | N/A |
| H₂O₂-induced oxidative stress in isolated chondrocytes | exploratory | Temporomandibular joint osteoa | 0.900 | 0.00 | Isolated chondrocytes | proposed | N/A |
| Unilateral anterior crossbite (UAC) model of TMJOA in rats | validation | Temporomandibular joint osteoa | 0.900 | 0.00 | Rats with unilateral anterior | proposed | N/A |
| Gap26 inhibitor treatment in cellular TMJOA model | exploratory | Temporomandibular joint osteoa | 0.900 | 0.00 | H₂O₂-treated chondrocytes with | proposed | N/A |
| Gap26 treatment in UAC rat model of TMJOA | validation | Temporomandibular joint osteoa | 0.800 | 0.00 | UAC rats treated with Gap26 in | proposed | N/A |
| Cx43-β-catenin protein-protein interaction analysis | exploratory | Temporomandibular joint osteoa | 0.800 | 0.00 | Cell-based protein interaction | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Genome-wide consensus transcriptional signatures identify synaptic pruning linki [PMID:41139712] | Li H, Xie Z, Tian Y, Zhou R, Yang Y et a | Mol Psychiatry | 2026 | 0 |
| The Alzheimer's disease risk genes MS4A4A and MS4A6A cooperate to negatively reg [PMID:41435829] | Rosner D, Sun J, Cacace R, Yee A, Wagh C | Neuron | 2026 | 0 |
| Extracellular vesicles from IPFP-MSCs trigger osteoarthritis by transferring mtD [PMID:41480405] | Li S, Yan Z, Zhi X, Zheng W, Zhang Z et | Bioact Mater | 2026 | 0 |
| Integrative Transcriptomic and Bioinformatics Approaches Combined With Transform [PMID:41524613] | Yan D, Li W, Xing E, Wang P, Zhang Z | FASEB J | 2026 | 0 |
| Comprehensive multi-omics analysis and experimental validation indicate that VPS [PMID:41531939] | Wan D, Qi Y, Kang Y, Liang F, Wang Q et | RSC Med Chem | 2026 | 0 |
| Integrated Bioinformatics Analysis of Screen Mitochondrial Autophagy-Related Cor [PMID:41731906] | Gao Z, Wang Y, Ren Y, Lyu J | J Neurochem | 2026 | 0 |
| VPS35 Deficiency Markedly Reduces the Proliferation of HEK293 Cells. [PMID:41751560] | Lee S, Park S, Bang H, Kim SU, Park YH e | Genes (Basel) | 2026 | 0 |
| N-acetyl-l-leucine lowers α-synuclein levels and improves synaptic function in P [PMID:41766663] | Song P, Chen C, Franchini R, Duong B, Wa | J Clin Invest | 2026 | 0 |
| The VPS35 protein and the role of its impairments in mitochondrial dysfunction i [PMID:41841708] | Buneeva OA, Medvedev AE | Biomed Khim | 2026 | 0 |
| Vps35 p. D620N causes Lrrk2 kinase hyperactivity, chronic microglial activation [PMID:41846978] | Deng IB, Bu M, Follett J, Sharp R, Mamai | bioRxiv | 2026 | 0 |
| Lack of Cerebrospinal Fluid α-Synuclein Seeding in VPS35 D620N- and LRRK2 Y1699C [PMID:41912440] | Santinelli L, Pratuseviciute N, Lange LM | Mov Disord | 2026 | 0 |
| Integrative bioinformatics and machine learning identify shared molecular mechan [PMID:41961800] | Deng A, Wang W | PLoS One | 2026 | 0 |
| Genome-wide consensus transcriptional signatures identify synaptic pruning linki [PMID:41139712] | Li H, Xie Z, Tian Y, Zhou R, Yang Y, Lin | Molecular psychiatry | 2026 | 0 |
| The Alzheimer's disease risk genes MS4A4A and MS4A6A cooperate to negatively reg [PMID:41435829] | Rosner D, Sun J, Cacace R, Yee A, Wagh C | Neuron | 2026 | 0 |
| Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. [PMID:20301376] | Adam, Bick, Mirzaa, Pagon, Wallace et al | 1993 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning AGE in their description or question text
Score: 0.745 · neurodegeneration · 2026-04-12
**Molecular Mechanism and Rationale** The NAD+ salvage pathway represents a critical metabolic hub in neuronal energy h
Score: 0.740 · neurodegeneration · 2026-04-21
## Mechanistic Overview VPS35 retromer activation prevents endosomal tau templating across all brain regions and disease
Score: 0.740 · neurodegeneration · 2026-04-24
A credible refinement is that any true amplification is not universal across cell types, but emerges most strongly in pr
Score: 0.735 · Alzheimer's disease · 2026-04-04
## Mechanistic Overview Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Ph
Score: 0.724 · cell biology · 2026-04-13
## Mechanistic Overview Context-Dependent Cx43 Modulation Based on Disease Stage starts from the claim that modulating G
Score: 0.693 · neuroinflammation · 2026-04-21
**Molecular Mechanism and Rationale** The proposed mechanism centers on liver disease-induced breakdown of blood-brain
Score: 0.661 · neurodegeneration · 2026-04-15
## Mechanistic Overview PARP1 Inhibition Blocks Poly(PR)-Triggered DNA Damage and Subsequent p53 Activation starts from
Score: 0.660 · drug delivery · 2026-04-22
## **Molecular Mechanism and Rationale** The molecular foundation of focused ultrasound (FUS) with microbubble contrast
Score: 0.652 · neurodegeneration · 2026-04-25
Autophagosomes still form after irradiation, but damaged lysosomes cannot clear cargo, sustaining ROS and SASP output.
Score: 0.649 · neurodegeneration · 2026-04-17
**Molecular Mechanism and Rationale** The TREM2 (Triggering Receptor Expressed on Myeloid cells 2) signaling pathway re
Score: 0.648 · neuroinflammation · 2026-04-13
## Mechanistic Overview IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral Tolerance Through Macrophage Reprog
Score: 0.647 · unknown disease · 2026-04-26
S100B operates as a pathogenic DAMP in the perivascular space, binding RAGE on brain endothelial cells to trigger NF-κB-
Score: 0.640 · neuroinflammation · 2026-04-21
**Molecular Mechanism and Rationale** The C1Q complement system component represents a critical bridge between innate i
Score: 0.640 · neurodegeneration · 2026-04-25
Electron leak at complex I and destabilized inner-membrane architecture generate superoxide and lipid oxidation that dam
Score: 0.640 · neurodegeneration · 2026-04-25
This hypothesis posits that mild hyperbaric oxidative stress activates Nrf2-ARE transcriptional programs, upregulating S